Overview

Treatment of Intrauterine Growth Restriction With Low Molecular Heparin.

Status:
Unknown status
Trial end date:
2019-12-01
Target enrollment:
Participant gender:
Summary
TREATMENT OF INTRAUTERINE GROWTH RESTRICTION WITH LOW MOLECULAR WEIGHT HEPARIN.
Phase:
Phase 3
Details
Lead Sponsor:
Fundació Sant Joan de Déu
Collaborator:
Servicio de Asesoría a la Investigación y Logística SL
Treatments:
Calcium heparin
Dalteparin
Heparin
Heparin, Low-Molecular-Weight
Tinzaparin